Skip to main content

Philadelphia Trust Co

SEC CIK
0001110806
Latest filing
Aug 10, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Philadelphia Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q1 2021
Holdings of RPRX by Philadelphia Trust Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−58,095−100.0%Sold outHolders
Q2 202358,095$1.79M0.2%−155,335−72.8%ReducedHolders
Q1 2023213,430$7.69M0.8%−6,510−3.0%ReducedHolders
Q4 2022219,940$8.69M0.9%−8,310−3.6%ReducedHolders
Q3 2022228,250$9.17M1.0%−3,295−1.4%ReducedHolders
Q2 2022231,545$9.73M1.0%+1,860+0.8%AddedHolders
Q1 2022229,685$8.95M0.7%+1,750+0.8%AddedHolders
Q4 2021227,935$9.08M0.7%−3,370−1.5%ReducedHolders
Q3 2021231,305$8.36M0.6%+58,280+33.7%AddedHolders
Q2 2021173,025$7.09M0.5%+550+0.3%AddedHolders
Q1 2021172,475$7.52M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.